MODELS OF HLA-DPB1 PERMISSIVENESS AND UNRELATED DONOR HEMATOPOIETIC CELL TRANSPLANTATION
DOI:
https://doi.org/10.46765/2675-374X.2024v5n1p221Abstract
In current allo-HCT practice, a fully HLA-matched sibling donor is the best donor associated with improved transplant outcomes. When a matched sibling donor is unavailable, the second best available donor option is a matched unrelated donor (MUD), either HLA 8/8 or HLA 10/10. One notable characteristic in the MUD setting is that HLA-DPB1 mismatches are present in around 80/85% of unrelated donor/recipient pairs. This unique feature has an additional layer of complexity as these HLA-DPB1 incompatibilities may be further divided into permissive and non-permissive mismatches by two biological-driven permissiveness models, namely T-cell epitope (TCE) and DP expression. In the current review article, we described the basics of T-cell allorecognition, the unique HLA-DPB1 immunogenetics, the early conflicting results regarding HLA-DPB1 mismatching in allo-HCT, the development and the clinical impact of T-cell epitope and Expression models, the new indirect allorecognition algorithm of HLA-DPB1 permissiveness (PIRCHE model), the role of HLA-DPB1 in nonmalignant disease setting, and future perspectives on HLA-DPB1 permissiveness.
Keywords: HLA-DPB1, Permissive mismatch, Unrelated donor
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 JOURNAL OF BONE MARROW TRANSPLANTATION AND CELLULAR THERAPY
This work is licensed under a Creative Commons Attribution 4.0 International License.
License and Copyright Policy
The Journal of Bone Marrow Transplantation and Cellular Therapy (JBMTCT) adopts an open access policy, ensuring that all published articles are freely available to the public without restrictions.
-
License
- All articles published in JBMTCT are licensed under the Creative Commons Attribution 4.0 International License (CC BY 4.0).
- This license permits anyone to:
- Share: Copy and redistribute the material in any medium or format.
- Adapt: Remix, transform, and build upon the material for any purpose, even commercially.
- The only requirement is that appropriate credit is given to the original authors and source, a link to the license is provided, and any changes made are indicated.
More information about the license can be found here: Creative Commons Attribution 4.0 International License.
-
Authors’ Rights
- Authors retain the copyright to their work.
- Authors grant JBMTCT the right to publish the work and make it openly accessible online.
- Authors are free to:
- Distribute the published version of their article (e.g., post it on personal websites or institutional repositories).
- Use the article in future works, presentations, or derivative publications, as long as the original publication in JBMTCT is properly acknowledged.
-
No Embargo
- There is no embargo period; articles are made freely available immediately upon publication.
-
Ethical Use
- Users of JBMTCT articles must ensure proper citation of the authors and the journal.
- Articles must not be used in ways that violate ethical or legal standards.
-
Disclaimer
- While JBMTCT aims to ensure the accuracy and reliability of published content, the journal and its editors are not responsible for the consequences of its use.
For any questions regarding our licensing terms, please contact us at: journalbmtct@sbtmo.org.br
JBMTCT is committed to the principles of open access to advance knowledge and scientific collaboration.
